WAY Stock Overview
Develops a cloud-based software solution for healthcare payments. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for WAY from our risk checks.
Waystar Holding Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$30.88 |
52 Week High | US$33.25 |
52 Week Low | US$20.26 |
Beta | 0 |
11 Month Change | 7.33% |
3 Month Change | 16.44% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 49.18% |
Recent News & Updates
Recent updates
Shareholder Returns
WAY | US Healthcare Services | US Market | |
---|---|---|---|
7D | -0.3% | 1.6% | 0.7% |
1Y | n/a | 12.2% | 32.2% |
Return vs Industry: Insufficient data to determine how WAY performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how WAY performed against the US Market.
Price Volatility
WAY volatility | |
---|---|
WAY Average Weekly Movement | 3.4% |
Healthcare Services Industry Average Movement | 9.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: WAY has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: WAY's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | 1,400 | Matt Hawkins | waystar.com |
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry.
Waystar Holding Corp. Fundamentals Summary
WAY fundamental statistics | |
---|---|
Market cap | US$5.31b |
Earnings (TTM) | -US$52.62m |
Revenue (TTM) | US$906.14m |
5.9x
P/S Ratio-101.0x
P/E RatioIs WAY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
WAY income statement (TTM) | |
---|---|
Revenue | US$906.14m |
Cost of Revenue | US$303.38m |
Gross Profit | US$602.77m |
Other Expenses | US$655.38m |
Earnings | -US$52.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.31 |
Gross Margin | 66.52% |
Net Profit Margin | -5.81% |
Debt/Equity Ratio | 40.5% |
How did WAY perform over the long term?
See historical performance and comparison